These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11713940)

  • 1. Stevens-Johnson Syndrome and cholestatic hepatitis.
    Morelli MS; O'Brien FX
    Dig Dis Sci; 2001 Nov; 46(11):2385-8. PubMed ID: 11713940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe cholestatic hepatitis associated with Stevens-Johnson syndrome after taking ibuprofen].
    Elkrief L; Chryssostalis A; Moachon L; Franck N; Terris B; Chaussade S; Sogni P
    Gastroenterol Clin Biol; 2007 Nov; 31(11):1043-5. PubMed ID: 18166906
    [No Abstract]   [Full Text] [Related]  

  • 3. Paracetamol-induced Stevens Johnson syndrome and cholestatic hepatitis.
    Slim R; Fathallah N; Aounallah A; Ksiaa M; Sriha B; Nouira R; Ben Salem C
    Curr Drug Saf; 2015; 10(2):187-9. PubMed ID: 25158788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?
    Mawson AR; Eriator I; Karre S
    Med Sci Monit; 2015 Jan; 21():133-43. PubMed ID: 25579087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine-induced Stevens-Johnson syndrome and liver injury.
    Agrawal R; Almoghrabi A; Attar BM; Gandhi S
    J Clin Pharm Ther; 2019 Feb; 44(1):115-118. PubMed ID: 30296343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical mesalazine as a cause of Stevens-Johnson syndrome.
    Núñez Ortiz A; Trigo Salado C; de la Cruz Ramírez MD; Herrera Justiniano JM; Leo Carnerero E
    Rev Esp Enferm Dig; 2018 Nov; 110(11):736-738. PubMed ID: 29931986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
    Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population.
    Patel TK; Barvaliya MJ; Sharma D; Tripathi C
    Indian J Dermatol Venereol Leprol; 2013; 79(3):389-98. PubMed ID: 23619444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
    J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature.
    Ward KE; Archambault R; Mersfelder TL
    Am J Health Syst Pharm; 2010 Feb; 67(3):206-13. PubMed ID: 20101062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome plus intrahepatic cholestasis caused by clindamycin or chlorpheniramine].
    Sahagún Flores JE; Soto Ortiz JA; Tovar Méndez CE; Cárdenas Ochoa EC; Hernández Flores G
    Dermatol Online J; 2009 May; 15(5):12. PubMed ID: 19624990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis as adjuvant therapy in Stevens-Johnson syndrome and hepatic encephalopathy.
    Hung PC; Wang HS; Hsia SH; Wong AM
    Brain Dev; 2014 Apr; 36(4):356-8. PubMed ID: 23777679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome plus toxic hepatitis due to ibuprofen.
    Sternlieb P; Robinson RM
    N Y State J Med; 1978 Jul; 78(8):1239-43. PubMed ID: 276660
    [No Abstract]   [Full Text] [Related]  

  • 17. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.
    Ueta M
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES183-DES191. PubMed ID: 30481825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute vanishing bile duct syndrome after ibuprofen therapy in a child.
    Taghian M; Tran TA; Bresson-Hadni S; Menget A; Felix S; Jacquemin E
    J Pediatr; 2004 Aug; 145(2):273-6. PubMed ID: 15289784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.